GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (NAS:VALN) » Definitions » Other Current Assets

VALN (Valneva SE) Other Current Assets : $65.6 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Valneva SE Other Current Assets?

Valneva SE's other current assets for the quarter that ended in Sep. 2024 was $65.6 Mil.

Valneva SE's quarterly other current assets increased from Mar. 2024 ($58.4 Mil) to Jun. 2024 ($62.8 Mil) and increased from Jun. 2024 ($62.8 Mil) to Sep. 2024 ($65.6Mil).

Valneva SE's annual other current assets increased from Dec. 2021 ($80.3 Mil) to Dec. 2022 ($83.8 Mil) declined from Dec. 2022 ($83.8 Mil) to Dec. 2023 ($55.2 Mil).


Valneva SE Other Current Assets Historical Data

The historical data trend for Valneva SE's Other Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valneva SE Other Current Assets Chart

Valneva SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.58 70.40 80.32 83.80 55.22

Valneva SE Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 71.56 55.22 58.40 62.81 65.58

Valneva SE Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:


Cash
Trade Receivables
Inventory

The assets grouped under other current assets are most commonly:


Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.


Valneva SE Other Current Assets Related Terms

Thank you for viewing the detailed overview of Valneva SE's Other Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Valneva SE Business Description

Traded in Other Exchanges
Address
6 Rue Alain Bombard, Saint-Herblain, FRA, 44800
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.

Valneva SE Headlines

From GuruFocus

Valneva SE Analyst Call Transcript

By GuruFocus Research 02-09-2024

Half Year 2022 Valneva SE Earnings Call Transcript

By GuruFocus Research 02-09-2024

Valneva SE Annual Shareholders Meeting Transcript

By GuruFocus Research 02-09-2024

Full Year 2020 Valneva SE Earnings Call Transcript

By GuruFocus Research 02-09-2024

Full Year 2022 Valneva SE Earnings Call Transcript

By GuruFocus Research 02-09-2024

Q1 2023 Valneva SE Earnings Call Transcript

By GuruFocus Research 02-09-2024

Valneva SE - Special Call Transcript

By GuruFocus Research 02-09-2024

Q3 2024 Valneva SE Earnings Call Transcript

By GuruFocus News 11-08-2024